littl noisi fundament
transform stori remain intact see
modest underli improv doubl digit ep ex-sbc
pipelin ahead lrp schedul path
durabl profil real catalyst out-performance
 may need achiev outcom
top-line result line ep upsid help sbc hill-rom report
revenu bp vs mse repres core growth
line mse ep vs mse includ
benefit stock-bas compens sbc result execut chang
growth pt easier comp reflect pt momentum
deceler given pipelin momentum discuss result
shown least stabl momentum sequenti core growth basi
think ex us pressur off-set ex us perform mix
hill-rom note manag made chang asia-pacif leadership
commit improv go forward realiti hill-rom still
capit busi intern mix capit base volatil
still dynam investor must contend quarterli pleas see exhibit
reconcili result vs mse
top-line growth balanc growth guidanc patient
support system pss front line flc surgic solut ss
repres balanc growth seen year call hill-
rom also announc new classifi oem busi primarili
intern ss non-cor go forward drive bp benefit
core growth investor patienc may wear thin new non-cor
disclosur note pipelin drive major growth next year
pipelin product estim reach revenu well
ahead lrp target increment y/i
revenu drive pt core growth net new non-cor disclosur see
core growth guidanc core growth like-for-lik basi vs
core growth see major growth come
pipelin product hill-rom multi-year transform continu
ep growth optic weaker underli still doubl digit
affect growth rate hill-rom guid ep growth next year
midpoint see consist primarili pt report revenu
growth pt bp margin expans off-set pt higher
medic technolog unit state america
unless otherwis note metric base modelwar
consensu data provid thomson reuter estim
seek busi
compani cover morgan stanley research
result investor awar firm may
conflict interest could affect object
morgan stanley research investor consid
morgan stanley research singl factor make
invest decis
analyst certif import disclosur
refer disclosur section locat end
tax rate adjust modestli lower non-op modestli higher
share count howev lower ep growth may seem disappoint
note hill-rom offset pt tariff headwind
adjust ep base stock-bas compens
suggest ep growth adopt affect
report number manag expect affect
pipelin well ahead lrp schedul confer call hill-rom
indic pipelin product contribut revenu ytd
estim put compani track exceed annual
target pipelin revenu actual came littl sharpli
outperform origin target run rate sequenti
traction broad-bas across sever product estim
pipelin product primarili consist centrella
remaind mainli split connex tabl motion vision product
retinavu vision acceler pipelin encourag
given see pipelin increasingli larger driver growth discuss
improv visibl lrp target collect
repres almost address market opportun leav us
comfort sustain growth
transform drive modest underli acceler discuss
downgrad earlier year continu see lrp achiev
believ hill-rom transform increasingli reflect
consensu estim solid execut drive multipl expans hill-rom
result evid core growth guidanc show
broad-bas strength pipelin progress provid increas
visibl durabl growth said net chang
guidanc number move materi maintain price
target reflect ev/ebitda estim discount
smid cap peer reflect slower growth higher leverag consist
execut lead us revalu multipl path durabl profil
real catalyst out-performance may need achiev
outcom note manag discuss use way move
growth higher howev knowledg potenti deal
price target reflect ev/ebitda multipl
discount smid cap med-tech given leverag lower growth
new product launch growth exceed expect cost initi
take margin higher new product launch perform better expect
underli margin surpass top hill-rom lrp driven revenu upsid
mix cost initi progress ahead schedul hill-rom manag
remain focus addit deal compani delev
hill-rom growth stabil mid-singl digit pipelin product move hill-
rom structur organ growth rate time mix cost
initi drive margin line lrp improv stabil
growth visibl margin improv drive multipl higher
long-term plan materi sale see moder growth
slowdown capital-expenditure environ hurt pss pipelin fail
materi expect initi materi manag
expect along top-line shortfal drive limit margin
improv multipl fall lrp fail materi
multipl re-rat given divers improv growth
multipl re-rat given divers improv growth
hill-rom multipl re-rat
growth move higher volatil
decreas hill-rom sale base
diversifi number driver
increas hill-rom organ
growth rate divestitur non-cor product
lrp achiev
achiev prior lrp target year earli
hill-rom new lrp call growth
trend toward
along oper margin
target see new lrp
achiev product pipelin
robust time around end market
mix improv
hospit capital-expenditure environ hill-
rom revenu expos hospit
centrella contribut
sale expect contribut
sale
divestitur non-cor asset improv
growth profil on-going
progress cost restructur on-going
uptak recent product launch
risk achiev price
pipelin traction slow fail
materi upcom product
margin leverag prove difficult
materi shift capital-expenditure environ
million except ep
good sold
dollar million except per share data
total revenu
less net incom non-controlling interest
net incom sharehold
dollar million except per share data
dollar million except per share data
invest invest secur
softwar net
note receiv net discount
accru pension postretir benefit
addit paid capit
dollar million except per share data
net realiz capit loss gain equiti method invest incom loss
provis defer incom tax
chang oper asset liabil
net provid oper activ
capit expenditur purchas intang
proce dispos properti equip leas
proce sale non-strateg asset
payment acquisit busi net cash
invest purchas capit call
proce invest sale matur
net use invest activ
net chang short-term debt net debt issuanc cost
payment long-term debt net proce settlement interest rate swap includ payment/borrow revolv
distribut non-controlling interest partner
net chang equiti
effect exchang rate ce
net chang
equival bop
equival eop
